The treponema pallidum tests market is likely to register robust growth in the near future. The advancements in various testing techniques has resulted in development of laboratory culture of Treponema pallidum. Today, it is widely used for applications like gene expression and metabolism testing. Additionally, it is also used for the development of etiological agent culturing. However, the main application of the tests in the market remains in the detecting of syphilis. The tests are essential for detection of active syphilis. The growing incidences of these diseases and the widespread lack of awareness, and hard to detect symptoms of the disease are likely to drive significant growth for the treponema palliudum tests market.
US population underwent a severe health crisis in 2018 as sexually transmitted diseases hit a record all-time high. Among various STDs recorded in the year, there were 5,80,000 cases of Gnorrhea, 1,15,000 cases of Syphillia, and 1.7 million cases of Chlymedia. The numbers represented a 1,00,000 total increase in number of cases from the previous year. Additionally, the total number of STD incidents stand at around 2.4 million according to CDC. The center also pins causes of rising STDs on factors, many of which are on the rise. These include poverty, drug use, and unstable housing Moreover, as a result of these rising cases of Syphillis, the CDC recommended policy makers to check Syphillis at the first contact with health workers. The rising awareness, and subsequent growing awareness are likely to drive tremendous growth for the treponema pallidum market.
According to the latest CDC figures, nearly 77% of all Syphillis cases are found among MSMs or Men who have sexual relations with other men. Due to stigma attached to such sexual activities, this population is often left behind in diagnosis. Moreover, the lack of protection used during sexual intercourse is also a major reason for the spread of Syphillis in such cases. The good news here for the players in the Treponema pallidum market is, advancements in digital technologies are helping patients reach their healthcare providers anonymously. This has led to a significant rise of online portals for sexual health, which has become a billion dollar industry online in recent years. The stigma attached with sexual activity, and concerns like STDs or congenital Syphillis are expected to create several opportunities for new players in the treponema pallidum tests market.
The treponema pallidum tests market is expected to register highest growth in North America. The widespread awareness about STDs, the rising influx of start-ups surrounding sexual health, and rising cases of Syphillis are expected to drive significant growth for the market. Additionally, the growing reports by CDC, and infections rising among unborn children are expected to raise tremendous awareness about Syphillis testing and subsequent health concerns. The growth of Treponema Pallidum tests market in Asia Pacific is also likely to be robust. The large population in the region, rising liberalization of sexual conduct, and growing access to healthcare are expected to drive significant growth of the treponema pallidum tests market. The widespread adoption of testing in Europe, rising investment in advanced technologies, and widespread awareness about sexual health are expected to be major drivers of the treponema pallidum tests market.